AbCellera Biologics Inc vs NIO Inc. — how do they compare? AbCellera Biologics Inc trades at $8.99 (market cap $2.99B), while NIO Inc. trades at $4.57 (market cap $11.59B). The key difference: NIO Inc. is far larger — about 3.9× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, NIO Inc. nearer its low. Which is the better fit depends on your goals.
| ABCL | NIO | |
|---|---|---|
Market Cap | $2.99B | $11.59B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.76 | $7.89 |
52-Week Low | $2.78 | $4.44 |
Enterprise Value | $2.58B | $10.82B |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →